NEW YORK (GenomeWeb News) — Lab products maker Sartorius will buy a “substantial stake” in French company Stedim, which it plans to combine with its biotechnology division, Sartorius said last week.
 
Stedim makes disposable bag and door systems for biopharmaceutical use, and it owns a freeze-thaw technology, Sartorius said.
 
The new division would be called Sartorius Stedim Biotech, and would include seven board members from Sartorius and three from Stedim.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.